Compare GSK Pharma with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs ALEMBIC PHARMA - Comparison Results

GSK PHARMA     Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA ALEMBIC PHARMA GSK PHARMA/
ALEMBIC PHARMA
 
P/E (TTM) x 32.9 15.2 216.1% View Chart
P/BV x 13.1 3.8 346.1% View Chart
Dividend Yield % 1.2 1.0 120.0%  

Financials

 GSK PHARMA   ALEMBIC PHARMA
EQUITY SHARE DATA
    GSK PHARMA
Mar-19
ALEMBIC PHARMA
Mar-19
GSK PHARMA/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs3,595664 541.4%   
Low Rs1,253412 303.8%   
Sales per share (Unadj.) Rs184.7208.7 88.5%  
Earnings per share (Unadj.) Rs26.331.0 84.8%  
Cash flow per share (Unadj.) Rs29.237.1 78.6%  
Dividends per share (Unadj.) Rs20.005.50 363.6%  
Dividend yield (eoy) %0.81.0 80.7%  
Book value per share (Unadj.) Rs126.3144.2 87.6%  
Shares outstanding (eoy) m169.40188.52 89.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x13.12.6 509.1%   
Avg P/E ratio x92.217.4 531.0%  
P/CF ratio (eoy) x83.114.5 573.1%  
Price / Book Value ratio x19.23.7 514.2%  
Dividend payout %76.117.7 428.7%   
Avg Mkt Cap Rs m410,626101,461 404.7%   
No. of employees `0005.0NA-   
Total wages/salary Rs m5,3727,467 71.9%   
Avg. sales/employee Rs Th6,306.7NM-  
Avg. wages/employee Rs Th1,083.1NM-  
Avg. net profit/employee Rs Th898.0NM-  
INCOME DATA
Net Sales Rs m31,28139,347 79.5%  
Other income Rs m1,02394 1,090.8%   
Total revenues Rs m32,30439,441 81.9%   
Gross profit Rs m6,0098,736 68.8%  
Depreciation Rs m4861,152 42.2%   
Interest Rs m6184 3.3%   
Profit before tax Rs m6,5407,493 87.3%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-93 0.0%   
Extraordinary Inc (Exp) Rs m2870-   
Tax Rs m2,3731,568 151.4%   
Profit after tax Rs m4,4545,844 76.2%  
Gross profit margin %19.222.2 86.5%  
Effective tax rate %36.320.9 173.5%   
Net profit margin %14.214.9 95.9%  
BALANCE SHEET DATA
Current assets Rs m20,06119,577 102.5%   
Current liabilities Rs m14,54314,896 97.6%   
Net working cap to sales %17.611.9 148.3%  
Current ratio x1.41.3 105.0%  
Inventory Days Days5790 63.3%  
Debtors Days Days1445 31.0%  
Net fixed assets Rs m14,34327,097 52.9%   
Share capital Rs m1,694377 449.3%   
"Free" reserves Rs m19,70426,811 73.5%   
Net worth Rs m21,39827,188 78.7%   
Long term debt Rs m24,993 0.0%   
Total assets Rs m39,11347,778 81.9%  
Interest coverage x1,091.041.7 2,616.2%   
Debt to equity ratio x00.2 0.1%  
Sales to assets ratio x0.80.8 97.1%   
Return on assets %11.412.6 90.4%  
Return on equity %20.821.5 96.8%  
Return on capital %31.923.6 135.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m53419,453 2.7%   
Fx outflow Rs m7,0916,065 116.9%   
Net fx Rs m-6,55713,388 -49.0%   
CASH FLOW
From Operations Rs m3,9948,120 49.2%  
From Investments Rs m-1,433-7,556 19.0%  
From Financial Activity Rs m-3,584590 -607.0%  
Net Cashflow Rs m-1,0231,153 -88.7%  

Share Holding

Indian Promoters % 0.0 74.1 -  
Foreign collaborators % 50.7 0.0 -  
Indian inst/Mut Fund % 10.2 2.9 351.7%  
FIIs % 23.8 9.1 261.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 15.4 13.9 110.8%  
Shareholders   102,036 49,328 206.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   PIRAMAL ENTERPRISES  NOVARTIS  FRESENIUS KABI ONCO.  DR. REDDYS LAB  ABBOTT INDIA  

Compare GSK PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Frauds at Public Sector Banks, Upcoming IPOs, and Top Cues in Focus Today(Pre-Open)

India share markets ended their volatile day marginally lower yesterday. At the closing bell yesterday, the BSE Sensex stood lower by 76 points (down 0.2%).

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 398.9% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, GSK PHARMA has posted a net profit of Rs 5 bn (up 398.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 28.1% (Quarterly Result Update)

Jul 24, 2019 | Updated on Jul 24, 2019

For the quarter ended June 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 28.1% YoY). Sales on the other hand came in at Rs 8 bn (up 7.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

More Views on News

Most Popular

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

How the Modi Government is Helping My Top 7 Stocks(The 5 Minute Wrapup)

Nov 14, 2019

Recent reforms by the Modi government can give a big boost on your stocks, provided you buy the right ones.

I Think Nestle, HUL, and Asian Paints Could Give Low Returns(Profit Hunter)

Nov 15, 2019

If you think high quality stocks will continue their dream run forever, then you must read this now.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Nov 21, 2019 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE GSK PHARMA WITH

MARKET STATS